MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration

Neurodegenerative Diseases

Volumn 6, Issue 3, 2009, Pages 106-117

  Whitwell, Jennifer L ^a   Jack Jr , Clifford R ^a   Senjem, Matthew L ^a   Parisi, Joseph E ^a   Boeve, Bradley F ^a   Knopman, David S ^a   Dickson, Dennis W ^b   Petersen, Ronald C ^a   Josephs, Keith A ^a,c  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Autopsy; Clinical Dementia Rating Scale; Frontotemporal lobar degeneration; Mini Mental State Examination; TAR DNA binding protein 43; Tau; Voxel based morphometry

Indexed keywords

TAR DNA BINDING PROTEIN; TAU PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOBASAL DEGENERATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HIPPOCAMPUS; HUMAN; INSULA; MALE; MORPHOMETRICS; MOTOR NEURON DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RATING SCALE; SEX DIFFERENCE; TEMPORAL CORTEX;

ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 62449145479     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000209507     Document Type: Article

References (54)

1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
2. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133
3. Josephs KA: Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol 2008; 64: 4-14.
4. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, Khan N, Al-Sarraj S, Revesz T: Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004; 30: 369-373.
5. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M: Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-962. 1 Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611. 2 Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
6. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM: Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
7. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW: Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-48.
8. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG: The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
9. Josephs KA, Whitwell JL, Dickson DW, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Jack CR Jr: Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008; 29: 280-289.
10. Whitwell JL, Jack CR Jr, Senjem ML, Josephs KA: Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 2006; 66: 102-104.
11. Whitwell JL, Josephs KA, Rossor MN, Stevens JM, Revesz T, Holton JL, Al-Sarraj S, Godbolt AK, Fox NC, Warren JD: Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 2005; 62: 1402-1408.
12. Johnson JK, Diehl J, Mendez MF, Neuhaus J, Shapira JS, Forman M, Chute DJ, Roberson ED, Pace-Savitsky C, Neumann M, Chow TW, Rosen HJ, Forstl H, Kurz A, Miller BL: Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 2005; 62: 925-930.
13. Busatto GF, Garrido GE, Almeida OP, Castro CC, Camargo CH, Cid CG, Buchpiguel CA, Furuie S, Bottino CM: A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003; 24: 221-231.
14. Ferrarini L, Palm WM, Olofsen H, van der Landen R, Jan Blauw G, Westendorp RG, Bollen EL, Middelkoop HA, Reiber JH, van Buchem MA, Admiraal-Behloul F: MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease. Neuroimage 2008; 39: 1832-1838.
15. Fox NC, Scahill RI, Crum WR, Rossor MN: Correlation between rates of brain atrophy and cognitive decline in ad. Neurology 1999; 52: 1687-1689.
16. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP: Detection of gray matter loss in mild Alzheimer's disease with voxel-based morphometry. J Neurol Neurosurg Psychiatry 2002; 73: 657-664.
17. Jack CR Jr, Petersen RC, Xu YC, Waring SC, O'Brien PC, Tangalos EG, Smith GE, Ivnik RJ, Kokmen E: Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997; 49: 786-794.
18. Stout JC, Jernigan TL, Archibald SL, Salmon DP: Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch Neurol 1996; 53: 742-749.
19. Yamaguchi S, Meguro K, Shimada M, Ishizaki J, Yamadori A, Sekita Y: Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri project. Neuroradiology 2002; 44: 43-48.
20. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
21. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
22. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
23. Boeve BF, Lang AE, Litvan I: Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54(suppl 5): S15-S19.
24. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDSSPSP International Workshop. Neurology 1996; 47: 1-9.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
26. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
27. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, Mc-Donald WC, Braak H, Petersen RC: Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003; 62: 1087-1095.
28. Braak H, Braak E: Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989; 15: 13-26.
29. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M: Diagnosis and management of dementia with Lewy bodies: Third Report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
30. Hyman BT, Trojanowski JQ: Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 1095-1097.
31. Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW: Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch Neurol 2006; 63: 506-512.
32. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I: Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994; 44: 2015-2019.
33. Dickson DW, Bergeron C, Chin SS, Duyckaerts C, Horoupian D, Ikeda K, Jellinger K, Lantos PL, Lippa CF, Mirra SS, Tabaton M, Vonsattel JP, Wakabayashi K, Litvan I: Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935-946.
34. Dickson DW: Neuropathology of Pick's disease. Neurology 2001; 56:S16-S20.
35. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
36. Senjem ML, Gunter JL, Shiung MM, Petersen RC, Jack CR Jr: Comparison of different methodological implementations of voxelbased morphometry in neurodegenerative disease. Neuroimage 2005; 26: 600-608.
37. Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR Jr: Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007; 130: 708-719.
38. Whitwell JL, Jack CR, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA: oxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009;72:813-820. MRI in Autopsy-Confirmed FTLD Neurodegenerative Dis 2009;6:106-117 117 39
39. Whitwell JL, Warren JD, Josephs KA, Godbolt AK, Revesz T, Fox NC, Rossor MN: Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegener Dis 2004; 1: 225-230.
40. Kim EJ, Rabinovici GD, Seeley WW, Halabi C, Shu H, Weiner MW, DeArmond SJ, Trojanowski JQ, Gorno-Tempini ML, Miller BL, Rosen HJ: Patterns of MRI atrophy in taupositive and ubiquitin-positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2007; 78: 1375-1378.
41. Grossman M, Libon DJ, Forman MS, Massimo L, Wood E, Moore P, Anderson C, Farmer J, Chatterjee A, Clark CM, Coslett HB, Hurtig HI, Lee VM, Trojanowski JQ: Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol 2007; 64: 1601-1609.
42. Hoefer M, Allison SC, Schauer GF, Neuhaus JM, Hall J, Dang JN, Weiner MW, Miller BL, Rosen HJ: Fear conditioning in frontotemporal lobar degeneration and Alzheimer's disease. Brain 2008; 131: 1646-1657.
43. Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL: Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005; 128: 2612-2625.
44. Small DM, Zatorre RJ, Dagher A, Evans AC, Jones-Gotman M: Changes in brain activity related to eating chocolate: from pleasure to aversion. Brain 2001; 124: 1720-1733.
45. Whitwell JL, Sampson EL, Loy CT, Warren JE, Rossor MN, Fox NC, Warren JD: VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage 2007; 35: 207-213.
46. Wright P, He G, Shapira NA, Goodman WK, Liu Y: Disgust and the insula: FMRI responses to pictures of mutilation and contamination. Neuroreport 2004; 15: 2347-2351.
47. Hodges JR: Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology 2001; 56:S6-S10.
48. Snowden JS, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D: Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 2001; 70: 323-332.
49. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M: Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 1999; 52: 91-100.
50. Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C, Bianchetti A, Trabucchi M, Soininen H, Aronen HJ: Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry 2000; 47: 1056-1063.
51. Van de Pol LA, Hensel A, van der Flier WM, Visser PJ, Pijnenburg YA, Barkhof F, Gertz HJ, Scheltens P: Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2006; 77: 439-442.
52. Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC: Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 2006; 63: 1434-1439.
53. Seeley WW, Crawford R, Rascovsky K, Kramer JH, Weiner M, Miller BL, Gorno-Tempini ML: Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 2008; 65: 249-255.
54. Broe M, Hodges JR, Schofield E, Shepherd CE, Kril JJ, Halliday GM: Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003;60: 1005-1011.